Showing results (271-280 of 1,399) with videos related to

Sort By:
Pageof 140
Pharmacology Research & Perspectives|October 27, 2023
Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero-Test bile stringGuoying Tai, Fangming Xia, Cathy Chen, et al.
Pharmacology Research & Perspectives|March 25, 2024
Evaluation of OCT2-mediated drug-drug interactions between ulotaront and metformin in subjects with schizophreniaGuangqing Xiao, Hironobu Tsukada, Yu-Luan Chen, et al.
Pharmacology Research & Perspectives|January 11, 2024
Development of a pharmaceutical science systematic review process using a semi-automated machine learning tool: Intravenous drug compatibility in the neonatal intensive care settingD Thisuri N De Silva, Brioni R Moore, Tobias Strunk, et al.
Pharmacology Research & Perspectives|January 4, 2024
The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesityWen-Dong Xu, Shui-Zheng Lai, Jia Zhao, et al.
Pharmacology Research & Perspectives|January 4, 2024
Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safetyCheng Jiang, Jiancheng Qian, Xin Jiang, et al.
Pharmacology Research & Perspectives|December 27, 2023
Human organ chips for regenerative pharmacologyGirija Goyal, Chaitra Belgur, Donald E Ingber
Pharmacology Research & Perspectives|November 29, 2023
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptorMonica Patel, Natasha L Grimsey, Samuel D Banister, et al.
Pharmacology Research & Perspectives|November 28, 2023
A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patientsClaire Moore, Smaro Lazarakis, Tayla Stenta, et al.
Pharmacology Research & Perspectives|December 8, 2023
Co-created in vivo pharmacology practical classes using the novel organism Lumbriculus variegatusJulanta J Carriere, Nia A Davies, Margaret R Cunningham, et al.
Pharmacology Research & Perspectives|March 6, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic dosesJoanna Parkinson, Jesper Sundell, Dinko Rekić, et al.
Pageof 140